Clinical trials
Observational Disease Progression trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2015 | 7 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 7 |
| Massachusetts General Hospital | 4 |
| Monteris Medical | 3 |
| National Cancer Institute (NCI) | 3 |
| Duke University | 2 |
| Indiana University | 2 |
| Autoimmune Neurology Alliance | 1 |
| Cedars-Sinai Medical Center | 1 |
| Eli Lilly and Company | 1 |
| HIV Vaccine Trials Network | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease Progression | 48 |
| HIV Infections | 8 |
| Amyotrophic Lateral Sclerosis | 5 |
| Brain Neoplasms | 5 |
| Glaucoma | 3 |
| Neoplasm Metastasis | 3 |
| Recurrence | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Breast Neoplasms | 2 |
| COVID-19 | 2 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.